CUPERTINO, Calif., Oct. 22, 2026 – PRISM MediaWire (Press Release Service – Press Release Distribution) – Aemetis, Inc. (NASDAQ: AMTX), a diversified renewable natural gas and biofuels company, announced today that its Aemetis Biogas subsidiary has completed construction and started operation of two additional dairy biogas digesters as part of the company's biogas production network.
Options bears are circling three stocks today, with Aemetis Inc (NASDAQ:AMTX), Acadia Pharmaceuticals Inc (NASDAQ:ACAD), and Resideo Technologies Inc (NYSE:REZI) all seeing puts handily outpace calls.
Aemetis NASDAQ: AMTX reported higher second-quarter revenue and a return to operating profitability, citing growth in its California ethanol and dairy renewable natural gas businesses as well as contributions from federal Section 45Z production tax credits.
| Capital Markets Industry | Financials Sector | Eric A. McAfee CEO | PSX Exchange | US00770K2024 ISIN |
| US Country | 220 Employees | - Last Dividend | 15 Jun 2016 Last Split | 15 May 2014 IPO Date |
Aemetis, Inc. is a company that specializes in the production of renewable natural gas and renewable fuels, positioning itself as a pivotal player in the transition away from fossil-based products towards more sustainable alternatives. With its operations spanning across segments that include California Ethanol, California Dairy Renewable Natural Gas, and India Biodiesel, the company is dedicated to the operation, acquisition, development, and commercialization of innovative technologies. These efforts are aimed at producing fuels that not only have low carbon intensity but, in some cases, offer negative carbon intensity, thereby contributing to the reduction of the carbon footprint associated with energy consumption. Headquartered in Cupertino, California, Aemetis is at the forefront of leveraging conversion technologies and waste feedstocks to generate biofuels and biochemicals, aligning its mission with global sustainability goals.